Kraematon Investment Advisors, Inc Abbott Laboratories Transaction History
Kraematon Investment Advisors, Inc
- $93.8 Million
- Q1 2024
A detailed history of Kraematon Investment Advisors, Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Kraematon Investment Advisors, Inc holds 1,869 shares of ABT stock, worth $191,254. This represents 0.23% of its overall portfolio holdings.
Number of Shares
1,869
Previous 1,868
0.05%
Holding current value
$191,254
Previous $205,000
3.41%
% of portfolio
0.23%
Previous 0.23%
Shares
6 transactions
Others Institutions Holding ABT
# of Institutions
3,130Shares Held
1.29BCall Options Held
8.43MPut Options Held
8.71M-
Vanguard Group Inc Valley Forge, PA165MShares$16.9 Billion0.38% of portfolio
-
Black Rock Inc. New York, NY133MShares$13.6 Billion0.36% of portfolio
-
Capital Research Global Investors Los Angeles, CA84MShares$8.59 Billion2.23% of portfolio
-
State Street Corp Boston, MA74.7MShares$7.65 Billion0.39% of portfolio
-
Capital International Investors Los Angeles, CA70.2MShares$7.18 Billion1.65% of portfolio
About ABBOTT LABORATORIES
- Ticker ABT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 1,751,219,968
- Market Cap $179B
- Description
- Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...